Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 121

    Alembic Pharma to raise up to Rs 300 crore via issuance of NDCs

    Alembic Pharma to raise up to Rs 300 crore via issuance of NDCs

    Farhat Nasim13 Jun 2019 10:00 AM IST
    Alembic Pharma has approved the issue of unsecured listed rated redeemable non-convertible debentures (NCDs) of up to Rs 300 crore on a private...
    Reckitt Benckiser names PepsiCo executive Laxman Narasimhan as next CEO

    Reckitt Benckiser names PepsiCo executive Laxman Narasimhan as next CEO

    Medical Dialogues Bureau13 Jun 2019 9:30 AM IST
    Laxman Narasimhan (52) would join RB as CEO-designate and then would be appointed to the board of the company as an Executive Director with effect...
    Emerging drug DS-8201 could soon spell end of chemotherapy: Report

    Emerging drug DS-8201 could soon spell end of chemotherapy: Report

    Medical Dialogues Bureau13 Jun 2019 9:15 AM IST
    As importantly, its ability to target cancer cells without affecting normal cells is a key advantage over the take-no-prisoners approach of...
    Catalyst Pharma files lawsuit against USFDA challenging approval of Ruzurgi

    Catalyst Pharma files lawsuit against USFDA challenging approval of Ruzurgi

    Medical Dialogues Bureau13 Jun 2019 9:00 AM IST
    Ruzurgi was approved last month for treating Lambert-Eaton myasthenic syndrome that affects about one in 100,000 people in the United States.U.S:...
    Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore

    Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore

    Farhat Nasim12 Jun 2019 11:29 AM IST
    New Delhi: Yes Bank has reduced its stake in Fortis healthcare (FHL) by around 2 per cent by selling over 1.51 crore shares of the company in various...
    Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer

    Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer

    Medical Dialogues Bureau12 Jun 2019 9:50 AM IST
    The approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
    Eye care chain Disha Medical Services raises over Rs 27 crore in Series C funding

    Eye care chain Disha Medical Services raises over Rs 27 crore in Series C funding

    Medical Dialogues Bureau12 Jun 2019 9:45 AM IST
    Exiting investor Lok advised fund - Sarva Capital has been provided with a full exit as part of the current fundraising, Disha Medical Services said...
    Practo collaborates with Academy of Family Physicians of India to develop digital healthcare technology

    Practo collaborates with Academy of Family Physicians of India to develop digital healthcare technology

    Garima12 Jun 2019 9:36 AM IST
    New Delhi: Practo, a digital healthcare platform has signed an MOU with Academy of Family Physicians India (AFPI), an independent academic discipline...
    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit

    Medical Dialogues Bureau12 Jun 2019 9:30 AM IST
    Roche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Farhat Nasim11 Jun 2019 3:31 PM IST
    New Delhi: Bringing in a third party, the Delhi High Court has directed Radha Soami Satsang Beas (RSSB) chief Gurinder Singh Dhillon and his family...
    Abbott expands cardiac arrhythmias portfolio in India with launch of advanced mapping catheter

    Abbott expands cardiac arrhythmias portfolio in India with launch of advanced mapping catheter

    Farhat Nasim11 Jun 2019 12:28 PM IST
    Mumbai: Abbott today announced the launch of its HD grid mapping catheter, which is sensor enabled in India. This product received the USFDA clearance...
    Cipla receives inspection report from USFDA for Kurkumbh facility

    Cipla receives inspection report from USFDA for Kurkumbh facility

    Medical Dialogues Bureau11 Jun 2019 12:02 PM IST
    The Kurkumbh manufacturing facility was inspected by the United States Food and Drug Administration (USFDA) from March 11 to March 20, 2019, Cipla...
    PrevNext

    Popular Stories

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical...

    China offers tariff exemptions on US medical equipment amid virus outbreak

    China offers tariff exemptions on US medical equipment amid virus outbreak

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok